Groove (Paraduodenal) Pancreatitis

Definition & Anatomy

Epidemiology & Risk Factors

• More common in males
• Strong association with alcohol and tobacco use
• Presents similarly to other forms of chronic pancreatitis in terms of demographics — Current Surgical Therapy 14e, p. 669

Clinical Presentation

• Persistent abdominal pain
• Obstructive jaundice (biliary obstruction)
• Gastric outlet obstruction (duodenal involvement)
• Features of chronic pancreatitis (calcifications, parenchymal atrophy) are found in >35% of cases — Clinical Gastrointestinal Endoscopy 3e, p. 3890

Subtypes (Paraduodenal Classification)

Imaging

• Plate-like hypoattenuating, poorly enhancing lesion between the pancreatic head and descending duodenum
• Diffuse stranding and inflammatory changes surrounding the first portion of the duodenum and pancreatic head
• A curvilinear or cystic fluid collection in the groove — subtle but classic
• Pancreatic and/or bile duct dilatation may be present

• Hypovascular plate-like lesion in the groove
• Pathognomonic cystic changes within the lesion on T2-weighted imaging (see Fig. 25.23 D below)
• MRCP is important in the workup — shows both the hypovascular lesion and the cysts

Diagnostic Challenge: Mimicking Cancer

• Tumor markers (CA 19-9, CEA) are often negative in groove pancreatitis — supports benign diagnosis
• EUS-guided biopsy is often required to corroborate the diagnosis
• Cytology can be misleading — pancreatoduodenectomy is sometimes performed to definitively exclude malignancy — Current Surgical Therapy 14e, p. 669; Grainger & Allison's, p. 692

Management

Summary

Groove (Paraduodenal) Pancreatitis — Detailed Review

1. Terminology & Historical Context

• Groove pancreatitis — original descriptive term referring to the anatomical groove where inflammation occurs
• Paraduodenal pancreatitis — now the preferred term, reflecting the location adjacent to the duodenum
• Cystic dystrophy of the duodenum — an older term emphasizing the cystic wall changes in the duodenum

2. Anatomy of the "Groove"

• Anteriorly: the descending (second) part of the duodenum
• Medially: the head of the pancreas
• Posteriorly/superiorly: the common bile duct

3. Epidemiology & Risk Factors

• Predominantly affects middle-aged males
• Strong association with chronic heavy alcohol use and tobacco smoking — the same risk factors as classical chronic pancreatitis
• Less common than other forms of chronic pancreatitis, but clinically important because of its strong resemblance to pancreatic head cancer

4. Pathogenesis

1. Obstruction of the minor papilla (accessory duct): Alcohol/tobacco cause inspissation of secretions and ductal protein plugs → obstruction of the accessory pancreatic duct → pressure buildup in the groove → repeated episodes of local inflammation
2. Aberrant pancreatic heterotopia in the duodenal wall: Some cases arise from ectopic pancreatic tissue within the duodenal wall that undergoes inflammatory degeneration
3. Periductal fibrosis: Progressive fibrosis around the minor papilla leads to the plate-like fibrous mass seen on imaging

5. Pathological Subtypes

• Groove-predominant form: lesion confined to the groove, pancreatic parenchyma largely normal
• Segmental (pancreas-involving) form: lesion also involves the pancreatic head, making it nearly indistinguishable from pancreatic ductal adenocarcinoma — Grainger & Allison's, p. 692

6. Clinical Presentation

a) Abdominal Pain

• Persistent, severe, often epigastric, radiating to the back
• Chronic and relapsing — similar to other forms of chronic pancreatitis

b) Biliary Obstruction

• Obstructive jaundice — from compression or fibrotic involvement of the common bile duct passing through the inflamed groove
• May be the presenting symptom that triggers imaging

c) Gastric Outlet / Duodenal Obstruction

• Duodenal wall thickening and fibrosis → duodenal stenosis
• Manifests as early satiety, nausea, vomiting, postprandial pain
• Can be severe enough to require intervention — Current Surgical Therapy 14e, p. 669; Clinical GI Endoscopy 3e, p. 3890

• Weight loss (from reduced oral intake / malabsorption)
• Features of chronic pancreatitis (calcifications, parenchymal atrophy) in >35% of patients
• Pancreatic exocrine insufficiency may develop over time

7. Laboratory Findings

• Tumor markers (CA 19-9, CEA) are typically negative or only mildly elevated — this is a key distinguishing point from pancreatic cancer, though not absolute
• Serum amylase/lipase may be mildly elevated or normal in the chronic phase
• Liver function tests may show obstructive pattern (elevated bilirubin, alkaline phosphatase, GGT) if biliary obstruction is present
• No specific serologic marker for groove pancreatitis

8. Imaging

CT Scan

• Groove-predominant form: plate-like, hypoattenuating (low-density), poorly enhancing lesion situated between the pancreatic head and the descending duodenum (labeled "D" in the CT below — arrows point to the mass)
• Diffuse stranding and inflammatory changes surrounding the first portion of duodenum
• A curvilinear or cystic fluid collection in the groove — subtle but classic for groove pancreatitis
• Pancreatic and/or bile duct dilatation may be present
• The main pancreatic parenchyma is largely unaffected (groove-predominant form)
• Segmental form: the low-density mass extends into and involves the pancreatic head — difficult to distinguish from carcinoma

MRI / MRCP

• T1 GRE fat-suppressed: hypovascular (low signal) plate-like mass in the groove
• T2-weighted TSE: pathognomonic small cystic changes within the groove mass and in the duodenal wall — this cystic pattern is what distinguishes it most clearly from cancer
• MRCP additionally shows the cysts and any associated ductal changes

EUS (Endoscopic Ultrasound)

• Excellent for characterizing the groove lesion and the duodenal wall
• EUS-guided fine-needle aspiration (FNA) / biopsy is the key tool for tissue diagnosis when cancer cannot be excluded — Grainger & Allison's, p. 692; Current Surgical Therapy 14e, p. 669

9. Differential Diagnosis

10. Management

Conservative (First-line)

• Alcohol and tobacco cessation — essential
• Analgesics (step-up from NSAIDs to opioids for pain control)
• Nutritional support (pancreatic enzyme replacement if exocrine insufficiency)
• This is the treatment of choice when diagnosis is confirmed by biopsy

Endoscopic Therapy

• Pancreatic duct stenting — for main pancreatic duct strictures (~72.5% of cases have MPD stricture)
• Biliary stenting — for common bile duct obstruction (~57% of cases)
• EUS-guided transduodenal drainage of periduodenal cystic collections
• Subcutaneous octreotide as an adjunct (reduces pancreatic secretion)
• Reported clinical success rate >70% with combined endoscopic/medical therapy — Clinical GI Endoscopy 3e, p. 3890

Surgery — Pancreatoduodenectomy (Whipple Procedure)

1. Malignancy cannot be excluded — given the significant overlap with pancreatic cancer in the segmental form, resection is sometimes necessary as both a therapeutic and diagnostic maneuver
2. Failed conservative/endoscopic management — persistent biliary or duodenal obstruction not amenable to endoscopic therapy, or refractory pain
3. Cytology from EUS-FNA may be misleading (false negative or non-diagnostic), leading to surgery — Current Surgical Therapy 14e, p. 669; Yamada's Textbook of Gastroenterology

11. Key Teaching Points

1. Location is the key: inflammation confined to the anatomical groove between the pancreatic head and the descending duodenum — not diffuse pancreatitis
2. Cystic changes within the groove on T2 MRI are pathognomonic — look for small cysts in the groove and duodenal wall
3. Alcohol + male sex = typical patient profile
4. Negative tumor markers + absence of main duct obstruction + T2 cysts favor groove pancreatitis over cancer
5. The segmental form is the great mimic of pancreatic cancer — EUS-FNA is needed; surgery may still be required
6. Management is a stepwise approach: conservative → endoscopic → surgical (Whipple)